Sales skyrocket for weight-loss drug firm Novo Nordisk
Sales skyrocket for weight-loss drug firm Novo Nordisk
www.euronews.com Sales skyrocket for weight-loss drug firm Novo Nordisk
The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication.
4 comments
Why do I have a sneaking suspicion that in 5 years we'll be reading about what a disaster this pill turned out to be.
Also, I keep reading this as smegmaglutide.
3 0 ReplyIt’s an injection, not a pill. But yeah…
1 0 Reply
Studies show that once you stop using this drug, the weight returns in 2/3 of the former users.
1 0 Replywhich is why sales will continue to skyrocket
2 0 Reply